STEPHANIE HAM: Open Payments
NPI 1861001794 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 17 payments from 8 companies in 2025. Trend: 2023 $515 · 2024 $748 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $138 |
| Astellas Pharma US Inc | 4 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| ABBVIE INC. | 2 | $30 |
| EMD Serono, Inc. | 1 | $25 |
| Eisai Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: JEMPERLI, Vyloy, LUTATHERA, KISQALI, ELAHERE, ENHERTU, LYNPARZA, Lenvima.
Industry payments across TN — which companies pay providers there.
